XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 2 - Summary of Significant Accounting Policies - Impact of New Standard on Consolidated Balance Sheet and Consolidated Statements of Operations (Details) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Jan. 01, 2018
Dec. 31, 2017
Revenue $ 3,699,000 $ 3,041,000    
Cost of revenue 2,352,000 1,619,000    
Gross profit 1,347,000 1,422,000    
Loss from operations (11,340,000) (6,416,000)    
Comprehensive and net loss $ (12,669,000) $ (6,695,000)    
Basic and diluted (in dollars per share) $ (0.49) $ (0.57)    
Liabilities        
Accrued liabilities $ 4,257,000   $ 4,623,000 $ 4,605,000 [1]
Other noncurrent liabilities 218,000   132,000 327,000 [1]
Stockholders’ equity (deficit):        
Accumulated deficit (118,073,000)   $ (105,404,000) (105,581,000) [1]
Accounting Standards Update 2014-09 [Member]        
Gross profit 201,000      
Liabilities        
Accrued liabilities [2]       18,000
Other noncurrent liabilities [3]       (195,000)
Stockholders’ equity (deficit):        
Accumulated deficit [4]       $ 177,000
Calculated under Revenue Guidance in Effect before Topic 606 [Member]        
Revenue 3,489,000      
Cost of revenue 2,343,000      
Gross profit 1,146,000      
Loss from operations (11,541,000)      
Comprehensive and net loss $ (12,870,000)      
Basic and diluted (in dollars per share) $ (0.50)      
Liabilities        
Accrued liabilities $ 4,255,000      
Other noncurrent liabilities 598,000      
Stockholders’ equity (deficit):        
Accumulated deficit (118,451,000)      
Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | Accounting Standards Update 2014-09 [Member]        
Revenue [5] 210,000      
Cost of revenue [6] 9,000      
Gross profit [7] 201,000      
Loss from operations [7] 201,000      
Comprehensive and net loss [7] $ 201,000      
Basic and diluted (in dollars per share) [7] $ 0.01      
Liabilities        
Accrued liabilities [8] $ (2,000)      
Other noncurrent liabilities [9] 380,000      
Stockholders’ equity (deficit):        
Accumulated deficit [10] $ (378,000)      
[1] The condensed consolidated balance sheet as of December 31, 2017 has been derived from the audited consolidated financial statements as of that date.
[2] Change relates to future costs associated with extended warranties required to be recorded on adoption of ASC 606.
[3] Change relates to long-term deferred revenue related to the extended warranties not required to be recorded under ASC 606.
[4] Change relates to cumulative effect adjustment upon adoption of ASC 606.
[5] Change relates to revenue from extended assurance warranties for which no deferral is required on the adoption of ASC 606.
[6] Change relates to the future costs associated with extended assurance warranties required to be recorded on the adoption of ASC 606.
[7] Change relates to the net gain adjustment on the adoption of ASC 606.
[8] Change relates to future costs associated with extended warranties required to recorded on the adoption of ASC 606, partially offset by the current portion of deferred revenue in connection with the extended warranties not required to be recorded under ASC 606.
[9] Change relates to noncurrent portion of deferred revenue in connection with the extended warranties not required to be recorded under ASC 606.
[10] Change relates to $177,000 cumulative effect adjustment on the adoption of ASC 606 and the net gain adjustment of $201,000 for the three months ended March 31, 2018.